Seattle Genetics Debt to Equity Ratio 2006-2018 | SGEN

Current and historical debt to equity ratio values for Seattle Genetics (SGEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Seattle Genetics debt/equity for the three months ending September 30, 2018 was 0.00.
Seattle Genetics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $1.37B 0.00
2018-06-30 $0.00B $1.38B 0.00
2018-03-31 $0.00B $1.28B 0.00
2017-12-31 $0.00B $0.68B 0.00
2017-09-30 $0.00B $0.66B 0.00
2017-06-30 $0.00B $0.57B 0.00
2017-03-31 $0.00B $0.60B 0.00
2016-12-31 $0.00B $0.63B 0.00
2016-09-30 $0.00B $0.66B 0.00
2016-06-30 $0.00B $0.67B 0.00
2016-03-31 $0.00B $0.68B 0.00
2015-12-31 $0.00B $0.69B 0.00
2015-09-30 $0.00B $0.70B 0.00
2015-06-30 $0.00B $0.18B 0.00
2015-03-31 $0.00B $0.21B 0.00
2014-12-31 $0.00B $0.21B 0.00
2014-09-30 $0.00B $0.23B 0.00
2014-06-30 $0.00B $0.23B 0.00
2014-03-31 $0.00B $0.23B 0.00
2013-12-31 $0.00B $0.23B 0.00
2013-09-30 $0.00B $0.23B 0.00
2013-06-30 $0.00B $0.24B 0.00
2013-03-31 $0.00B $0.23B 0.00
2012-12-31 $0.00B $0.23B 0.00
2012-09-30 $0.00B $0.22B 0.00
2012-06-30 $0.00B $0.22B 0.00
2012-03-31 $0.00B $0.22B 0.00
2011-12-31 $0.00B $0.22B 0.00
2011-09-30 $0.00B $0.23B 0.00
2011-06-30 $0.00B $0.26B 0.00
2011-03-31 $0.00B $0.31B 0.00
2010-12-31 $0.00B $0.16B 0.00
2010-09-30 $0.00B $0.19B 0.00
2010-06-30 $0.00B $0.22B 0.00
2010-03-31 $0.00B $0.22B 0.00
2009-12-31 $0.00B $0.21B 0.00
2009-09-30 $0.00B $0.22B 0.00
2009-06-30 $0.00B $0.10B 0.00
2009-03-31 $0.00B $0.11B 0.00
2008-12-31 $0.00B $0.08B 0.00
2008-09-30 $0.00B $0.11B 0.00
2008-06-30 $0.00B $0.12B 0.00
2008-03-31 $0.00B $0.14B 0.00
2007-12-31 $0.00B $0.05B 0.00
2007-09-30 $0.00B $0.07B 0.00
2007-06-30 $0.00B $0.07B 0.00
2007-03-31 $0.00B $0.08B 0.00
2006-12-31 $0.00B $0.09B 0.00
2006-09-30 $0.00B $0.10B 0.00
2006-06-30 $0.00B $0.10B 0.00
2006-03-31 $0.00B $0.07B 0.00
2005-12-31 $0.00B $0.08B 0.00
2005-09-30 $0.00B $0.08B 0.00
2005-06-30 $0.00B $0.09B 0.00
2005-03-31 $0.00B $0.10B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.138B $0.482B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.200B 14.04
Gilead Sciences (GILD) United States $87.979B 10.59
Biogen (BIIB) United States $64.315B 13.02
Celgene (CELG) United States $48.528B 9.42
Illumina (ILMN) United States $44.334B 51.64
Vertex Pharmaceuticals (VRTX) United States $41.163B 71.91
Regeneron Pharmaceuticals (REGN) United States $36.682B 18.58
Alexion Pharmaceuticals (ALXN) United States $25.670B 17.57
BioMarin Pharmaceutical (BMRN) United States $16.686B 0.00
Incyte (INCY) United States $13.673B 377.94
Exact Sciences (EXAS) United States $8.269B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.107B 51.83
QIAGEN (QGEN) Netherlands $7.812B 24.99
Sarepta Therapeutics (SRPT) United States $7.776B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.222B 0.00
BeiGene (BGNE) Cayman Islands $6.685B 0.00
Bluebird Bio (BLUE) United States $6.531B 0.00
Bio-Techne Corp (TECH) United States $5.859B 39.58
Exelixis (EXEL) United States $5.292B 15.00
Alkermes (ALKS) Ireland $5.288B 3403.00
Galapagos (GLPG) Belgium $5.193B 0.00
Amarin (AMRN) Ireland $5.066B 0.00
Horizon Pharma Public (HZNP) Ireland $3.725B 15.32
Emergent Biosolutions (EBS) United States $3.551B 29.91
Immunomedics (IMMU) United States $3.513B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.493B 0.00
Array BioPharma (ARRY) United States $3.243B 0.00
Ligand Pharmaceuticals (LGND) United States $3.157B 24.15
Intercept Pharmaceuticals (ICPT) United States $3.079B 0.00
Allogene Therapeutics (ALLO) United States $3.057B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.813B 0.00
Guardant Health (GH) United States $2.809B 0.00
Repligen (RGEN) United States $2.727B 85.18
Genomic Health (GHDX) United States $2.651B 89.50
Akcea Therapeutics (AKCA) United States $2.646B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
China Biologic Products (CBPO) China $2.485B 17.69
Ascendis Pharma (ASND) Denmark $2.448B 0.00
Myriad Genetics (MYGN) United States $2.407B 23.84
Acceleron Pharma (XLRN) United States $2.375B 0.00
Allakos (ALLK) United States $2.330B 0.00
Blueprint Medicines (BPMC) United States $2.314B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.266B 0.00
MyoKardia (MYOK) United States $2.266B 0.00
Halozyme Therapeutics (HALO) United States $2.252B 50.26
REGENXBIO (RGNX) United States $2.148B 28.81
Arena Pharmaceuticals (ARNA) United States $2.019B 0.00
Amicus Therapeutics (FOLD) United States $1.948B 0.00
AnaptysBio (ANAB) United States $1.814B 0.00
Reata Pharmaceuticals (RETA) United States $1.800B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.767B 0.00
Denali Therapeutics (DNLI) United States $1.728B 0.00
Global Blood Therapeutics (GBT) United States $1.724B 0.00
Innoviva (INVA) United States $1.665B 9.42
Atara Biotherapeutics (ATRA) United States $1.617B 0.00
Cambrex (CBM) United States $1.597B 11.93
Aimmune Therapeutics (AIMT) United States $1.544B 0.00
Rubius Therapeutics (RUBY) United States $1.533B 0.00
Medicines (MDCO) United States $1.525B 0.00
NeoGenomics (NEO) United States $1.496B 123.69
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.427B 0.00
G1 THERAPEUTICS (GTHX) United States $1.411B 0.00
Spark Therapeutics (ONCE) United States $1.402B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.345B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.321B 0.00
Mirati Therapeutics (MRTX) United States $1.315B 0.00
Insmed (INSM) United States $1.314B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Editas Medicine (EDIT) United States $1.298B 0.00
Myovant Sciences (MYOV) United Kingdom $1.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.238B 98.33
Solid Biosciences (SLDB) United States $1.183B 0.00
WAVE Life Sciences (WVE) Singapore $1.146B 0.00
IMMURON LTD (IMRN) Australia $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.096B 0.00
Lion Biotechnologies (IOVA) United States $1.095B 0.00
UniQure (QURE) Netherlands $1.079B 0.00
Retrophin (RTRX) United States $1.075B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.999B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.982B 0.00
Audentes Therapeutics (BOLD) United States $0.970B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.937B 0.00
DBV Technologies (DBVT) France $0.917B 0.00
Acorda Therapeutics (ACOR) United States $0.910B 11.52
Cellectis (CLLS) France $0.904B 0.00
Puma Biotechnology (PBYI) United States $0.880B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.874B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.870B 0.00
Clovis Oncology (CLVS) United States $0.869B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.863B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.846B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.843B 0.00
Intra-Cellular Therapies (ITCI) United States $0.835B 0.00
Viking Therapeutics (VKTX) United States $0.833B 0.00
Apellis Pharmaceuticals (APLS) United States $0.810B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.805B 0.00
Fate Therapeutics (FATE) United States $0.793B 0.00
Coherus BioSciences (CHRS) United States $0.790B 0.00
Athenex (ATNX) United States $0.788B 0.00
Revance Therapeutics (RVNC) United States $0.775B 0.00
Aptinyx (APTX) United States $0.757B 0.00
Heska (HSKA) United States $0.753B 61.60
ProQR Therapeutics (PRQR) Netherlands $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.725B 0.00
Dynavax Technologies (DVAX) United States $0.723B 0.00
Vericel (VCEL) United States $0.721B 0.00
TWIST BIOSCIENC (TWST) United States $0.709B 0.00
Cara Therapeutics (CARA) United States $0.706B 0.00
Gritstone Oncology (GRTS) United States $0.688B 0.00
AC Immune SA (ACIU) Switzerland $0.671B 0.00
Novavax (NVAX) United States $0.659B 0.00
UROGEN PHARMA (URGN) Israel $0.644B 0.00
ANI Pharmaceuticals (ANIP) United States $0.635B 12.15
AMAG Pharmaceuticals (AMAG) United States $0.629B 0.00
Principia Biopharma (PRNB) United States $0.619B 0.00
InflaRx (IFRX) Germany $0.617B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.611B 0.00
CytomX Therapeutics (CTMX) United States $0.598B 0.00
Epizyme (EPZM) United States $0.594B 0.00
Senesco Technologies (ELOX) United States $0.592B 0.00
AVROBIO (AVRO) United States $0.577B 0.00
Arvinas (ARVN) United States $0.557B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.546B 0.00
RA PHARMCTL INC (RARX) United States $0.542B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.533B 0.00
Scholar Rock Holding (SRRK) United States $0.518B 0.00
Eidos Therapeutics (EIDX) United States $0.517B 0.00
UNITY Biotechnology (UBX) $0.513B 0.00
Arcus Biosciences (RCUS) United States $0.509B 0.00
BeyondSpring (BYSI) United States $0.505B 0.00
Anika Therapeutics (ANIK) United States $0.496B 20.52
Inovio Pharmaceuticals (INO) United States $0.478B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.475B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Kura Oncology (KURA) United States $0.472B 0.00
Replimune (REPL) United States $0.471B 0.00
Kezar Life Sciences (KZR) United States $0.455B 0.00
Mesoblast (MESO) Australia $0.454B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.450B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.437B 0.00
Kindred Biosciences (KIN) United States $0.421B 0.00
Sinovac Biotech (SVA) China $0.421B 0.00
PDL BioPharma (PDLI) United States $0.419B 6.83
Sorrento Therapeutics (SRNE) United States $0.407B 66.60
Five Prime Therapeutics (FPRX) United States $0.406B 0.00
Zymeworks (ZYME) Canada $0.403B 0.00
MediciNova (MNOV) United States $0.398B 0.00
Zealand Pharma (ZEAL) Denmark $0.391B 4.32
Achillion Pharmaceuticals (ACHN) United States $0.384B 0.00
Verastem (VSTM) United States $0.383B 0.00
Cytokineticsorporated (CYTK) United States $0.375B 0.00
Osiris Therapeutics (OSIR) United States $0.366B 0.00
Abeona Therapeutics (ABEO) United States $0.364B 0.00
MeiraGTx Holdings (MGTX) United States $0.353B 0.00
Merus (MRUS) Netherlands $0.352B 0.00
ResTORbio (TORC) United States $0.352B 0.00
Stemline Therapeutics (STML) United States $0.337B 0.00
Liquidia Technologies (LQDA) United States $0.334B 0.00
Seres Therapeutics (MCRB) United States $0.327B 0.00
Kodiak Sciences (KOD) United States $0.324B 0.00
LogicBio Therapeutics (LOGC) United States $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Albireo Pharma (ALBO) United States $0.301B 0.00
Krystal Biotech (KRYS) United States $0.298B 0.00
Geron (GERN) United States $0.287B 0.00
Kadmon Holdings (KDMN) United States $0.285B 0.00
Evelo Biosciences (EVLO) United States $0.278B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.276B 0.00
MannKind (MNKD) United States $0.276B 0.00
Athersys (ATHX) United States $0.272B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.271B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
BioDelivery Sciences (BDSI) United States $0.259B 0.00
Equillium (EQ) United States $0.259B 0.00
Celyad SA (CYAD) Belgium $0.254B 0.00
Magenta Therapeutics (MGTA) United States $0.254B 0.00
Agenus (AGEN) United States $0.251B 0.00
Syros Pharmaceuticals (SYRS) United States $0.248B 0.00
Arbutus Biopharma (ABUS) Canada $0.247B 0.00
Aduro Biotech (ADRO) United States $0.240B 0.00
Celcuity (CELC) United States $0.238B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.237B 0.00
Urovant Sciences (UROV) United States $0.237B 0.00
TOCAGEN INC (TOCA) United States $0.236B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.233B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Axovant Sciences (AXON) United Kingdom $0.231B 0.00
Unum Therapeutics (UMRX) United States $0.229B 0.00
Synlogic (SYBX) United States $0.223B 0.00
BioTime (BTX) United States $0.222B 0.00
Proteostasis Therapeutics (PTI) United States $0.219B 0.00
Kala Pharmaceuticals (KALA) United States $0.212B 0.00
Kamada (KMDA) Israel $0.211B 19.37
Sienna Biopharmaceuticals (SNNA) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Idera Pharmaceuticals (IDRA) United States $0.197B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.195B 0.00
ChromaDex (CDXC) United States $0.193B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.191B 0.00
Protagonist Therapeutics (PTGX) United States $0.190B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
Intec Pharma (NTEC) Israel $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Allena Pharmaceuticals (ALNA) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
NantKwest (NK) United States $0.166B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.163B 0.00
Compugen (CGEN) Israel $0.159B 0.00
PSivida (EYPT) United States $0.158B 0.00
Menlo Therapeutics (MNLO) United States $0.153B 0.00
XBiotech (XBIT) United States $0.150B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.149B 0.00
Cerecor (CERC) United States $0.146B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
Pfenex (PFNX) United States $0.142B 0.00
Spero Therapeutics (SPRO) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.138B 17.00
Eleven Biotherapeutics (SESN) United States $0.135B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
Cohbar (CWBR) United States $0.130B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.128B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Applied Genetic Technologies (AGTC) United States $0.125B 0.00
Mustang Bio (MBIO) United States $0.118B 0.00
XOMA (XOMA) United States $0.118B 0.00
VBI Vaccines (VBIV) United States $0.117B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.116B 0.00
Organovo Holdings (ONVO) United States $0.115B 0.00
Motif Bio Plc (MTFB) United States $0.114B 0.00
Anavex Life Sciences (AVXL) United States $0.105B 0.00
OVID THERAPEUTC (OVID) United States $0.103B 0.00
Signal Genetics (MGEN) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.102B 0.00
Cue Biopharma (CUE) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Provention Bio (PRVB) United States $0.098B 0.00
Chiasma (CHMA) United States $0.093B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Cocrystal Pharma (COCP) United States $0.089B 98.72
BioXcel Therapeutics (BTAI) United States $0.088B 0.00
Orgenesis (ORGS) United States $0.086B 0.00
VolitionRX (VNRX) Singapore $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Cel-Sci (CVM) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
Checkpoint Therapeutics (CKPT) United States $0.079B 0.00
Ophthotech (OPHT) United States $0.078B 0.00
ScPharmaceuticals (SCPH) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Fortress Biotech (FBIO) United States $0.074B 0.00
Alimera Sciences (ALIM) United States $0.074B 0.00
ITUS (ANIX) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Alcobra (ARCT) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
PHASEBIO PHARMA (PHAS) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.067B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Monster Digital (INNT) United States $0.065B 0.00
Versartis (ARAV) United States $0.063B 5.55
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Evogene (EVGN) Israel $0.062B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
Aptevo Therapeutics (APVO) United States $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Leap Therapeutics (LPTX) United States $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.054B 8.71
Oncobiologics (ONS) United States $0.053B 0.00
Trevena (TRVN) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 9.38
OncoSec Medical (ONCS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Oncolytics Biotech (ONCY) Canada $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.037B 0.00
TRACON Pharmaceuticals (TCON) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
GTx (GTXI) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
VIVUS (VVUS) United States $0.032B 0.00
BioPharmX (BPMX) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Therapix Biosciences (TRPX) Israel $0.028B 10.51
Histogenics (HSGX) United States $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
Oragenics (OGEN) United States $0.010B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00